Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032

Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A804
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Region
    5.4    Market Forecast
    5.5    Major Players
6   Global Generic Drug Delivery Market
    6.1    Oral
    6.2    Injectables
    6.3    Dermal/Topical
    6.4    Inhalers
7   Global Generic Injectables Market
    7.1    Market Overview
    7.2    Market Performance
    7.3    Impact of COVID-19
    7.4    Market Breakup by Region
    7.5    Market Breakup by Therapeutic Area
    7.6    Market Breakup by Container
    7.7    Market Breakup by Distribution Channel
    7.8    Market Forecast
    7.9    SWOT Analysis
        7.9.1 Overview
        7.9.2 Strengths
        7.9.3 Weaknesses
        7.9.4 Opportunities
        7.9.5 Threats
    7.10    Value Chain Analysis
    7.11    Porter’s Five Forces Analysis
        7.11.1 Overview
        7.11.2 Bargaining Power of Buyers
        7.11.3 Bargaining Power of Suppliers
        7.11.4 Degree of Competition
        7.11.5 Threat of New Entrants
        7.11.6 Threat of Substitutes
    7.12    Key Market Drivers and Success Factors
8   Global Generic Injectables Market: Performance of Key Regions
    8.1 North America
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2 Europe
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3 Asia
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4 Latin America
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5 Middle East and Africa
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Market by Therapeutic Area
    9.1 Oncology
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2 Anaesthesia
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3 Anti-infectives
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4 Parenteral Nutrition
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5 Cardiovascular
        9.5.1 Market Trends
        9.5.2 Market Forecast
10   Market by Container
     10.1 Vials
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Ampoules
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3 Premix
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 Prefilled Syringes
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  Market by Distribution Channel
    11.1 Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2 Retail Pharmacy 
        11.2.1 Market Trends
        11.2.2 Market Forecast
12  Global Generic Injectables Market: Competitive Landscape
    12.1    Market Structure
    12.2    Market Breakup by Key Players
13  Generic Injectables Manufacturing Process
    13.1    Product Overview
    13.2    Detailed Process Flow (Injectables)
    13.3    Various Types of Unit Operations Involved
    13.4    Mass Balance and Raw Material Requirements
14  Project Details, Requirements and Costs Involved
    14.1    Land Requirements and Expenditures
    14.2    Construction Requirements and Expenditures
    14.3    Plant Machinery
    14.4    Machinery Pictures
    14.5    Raw Material Requirements and Expenditures
    14.6    Packaging Requirements and Expenditures
    14.7    Transportation Requirements and Expenditures
    14.8    Utility Requirements and Expenditures
    14.9    Manpower Requirements and Expenditures
    14.10   Other Capital Investments
15  Loans and Financial Assistance
16  Project Economics

    16.1    Capital Cost of the Project
    16.2    Techno-Economic Parameters
    16.3    Product Pricing and Margins Across Various Levels of the Supply Chain
    16.4    Taxation and Depreciation
    16.5    Income Projections
    16.6    Expenditure Projections
    16.7    Financial Analysis
    16.8    Profit Analysis
17  Key Player Profiles
    17.1    Baxter International Inc.
        17.1.1 Company Overview
        17.1.2 Product Portfolio
        17.1.3 Financials
        17.1.4 SWOT Analysis
    17.2    Fresenius Kabi AG
        17.2.1 Company Overview
        17.2.2 Product Portfolio
        17.2.3 Financials
        17.2.4 SWOT Analysis
    17.3    Hikma Pharmaceuticals plc
        17.3.1 Company Overview
        17.3.2 Product Portfolio
        17.3.3 Financials
        17.3.4 SWOT Analysis
    17.4    Pfizer Inc.
        17.4.1 Company Overview
        17.4.2 Product Portfolio
        17.4.3 Financials
        17.4.4 SWOT Analysis
    17.5    Sagent Pharmaceuticals Inc. (Nichi-Iko Pharmaceutical Co. Ltd.)
        17.5.1 Company Overview
        17.5.2 Product Portfolio
        17.5.3 Financials
        17.5.4 SWOT Analysis
    17.6    Sandoz International GmbH (Novartis International AG)
        17.6.1 Company Overview
        17.6.2 Product Portfolio
        17.6.3 Financials
        17.6.4 SWOT Analysis
    17.7    Sanofi S.A.
        17.7.1 Company Overview
        17.7.2 Product Portfolio
        17.7.3 Financials
        17.7.4 SWOT Analysis

List of Figures

Figure 1: Global: Generic Drug Market: Value Trends (in Billion US$), 2018-2023
Figure 2: Global: Generic Drug Market: Breakup by Region (in %), 2023
Figure 3: Global: Generic Drug Market Forecast: Value Trends (in Billion US$), 2024-2032
Figure 4: Global: Generic Drug Delivery Market: Oral (in Million US$), 2018, 2023 & 2032
Figure 5: Global: Generic Drug Delivery Market: Injectables (in Million US$), 2018, 2023 & 2032
Figure 6: Global: Generic Drug Delivery Market: Dermal/Topical (in Million US$), 2018, 2023 & 2032
Figure 7: Global: Generic Drug Delivery Market: Inhalers (in Million US$), 2018, 2023 & 2032
Figure 8: Global: Generic Injectables Market: Value Trends (in Billion US$), 2018-2023
Figure 9: Global: Generic Injectables Market: Breakup by Region (in %), 2023
Figure 10: Global: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2023
Figure 11: Global: Generic Injectables Market: Breakup by Container (in %), 2023
Figure 12: Global: Generic Injectables Market: Breakup by Distribution Channel (in %), 2023
Figure 13: Global: Generic Injectables Market Forecast: Value Trends (in Billion US$), 2024-2032
Figure 14: Global: Generic Injectables Industry: SWOT Analysis
Figure 15: Global: Generic Injectables Industry: Value Chain Analysis
Figure 16: Global: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 17: North America: Generic Injectables Market (in Million US$), 2018 & 2023
Figure 18: North America: Generic Injectables Market Forecast (in Million US$), 2024-2032
Figure 19: Europe: Generic Injectables Market (in Million US$), 2018 & 2023
Figure 20: Europe: Generic Injectables Market Forecast (in Million US$), 2024-2032
Figure 21: Asia: Generic Injectables Market (in Million US$), 2018 & 2023
Figure 22: Asia: Generic Injectables Market Forecast (in Million US$), 2024-2032
Figure 23: Latin America: Generic Injectables Market (in Million US$), 2018 & 2023
Figure 24: Latin America: Generic Injectables Market Forecast (in Million US$), 2024-2032
Figure 25: Middle East and Africa: Generic Injectables Market (in Million US$), 2018 & 2023
Figure 26: Middle East and Africa: Generic Injectables Market Forecast (in Million US$), 2024-2032
Figure 27: Global: Generic Injectables (Oncology) Market: Value Trends (in Million US$), 2018 & 2023
Figure 28: Global: Generic Injectables (Oncology) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 29: Global: Generic Injectables (Anaesthesia) Market: Value Trends (in Million US$), 2018 & 2023
Figure 30: Global: Generic Injectables (Anaesthesia) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 31: Global: Generic Injectables (Anti-infectives) Market: Value Trends (in Million US$), 2018 & 2023
Figure 32: Global: Generic Injectables (Anti-infectives) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 33: Global: Generic Injectables (Parenteral Nutrition) Market: Value Trends (in Million US$), 2018 & 2023
Figure 34: Global: Generic Injectables (Parenteral Nutrition) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 35: Global: Generic Injectables (Cardiovascular) Market: Value Trends (in Million US$), 2018 & 2023
Figure 36: Global: Generic Injectables (Cardiovascular) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 37: Global: Generic Injectables (Vials) Market: Value Trends (in Million US$), 2018 & 2023
Figure 38: Global: Generic Injectables (Vials) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 39: Global: Generic Injectables (Ampoules) Market: Value Trends (in Million US$), 2018 & 2023
Figure 40: Global: Generic Injectables (Ampoules) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 41: Global: Generic Injectables (Premix) Market: Value Trends (in Million US$), 2018 & 2023
Figure 42: Global: Generic Injectables (Premix) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 43: Global: Generic Injectables (Prefilled Syringes) Market: Value Trends (in Million US$), 2018 & 2023
Figure 44: Global: Generic Injectables (Prefilled Syringes) Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 45: Global: Generic Injectables Market: Sales through Hospitals (in Million US$), 2018 & 2023
Figure 46: Global: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2024-2032
Figure 47: Global: Generic Injectables Market: Sales through Retail Pharmacy (in Million US$), 2018 & 2023
Figure 48: Global: Generic Injectables Market Forecast: Sales through Retail Pharmacy (in Million US$), 2024-2032
Figure 49: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 50: Generic Injectables Manufacturing: Detailed Process Flow
Figure 51: Generic Injectables Manufacturing: Production Cost Breakup (in %)
Figure 52: Generic Injectables Industry: Profit Margins at Various Levels of the Supply Chain
Figure 53: Generic Injectables Manufacturing Plant: Proposed Plant Layout
Figure 54: Generic Injectables Manufacturing Plant: Breakup of Capital Costs (in %)

List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Generic Drug Market Forecast: Breakup by Region, 2024-2032
Table 3: Global: Generic Drug Market: Revenues of Key Players (in Million US$), 2019
Table 4: Global: Generic Injectables Market: Key Industry Highlights, 2023 and 2032
Table 5: Global: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
Table 7: Global: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2024-2032
Table 8: Global: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 9: Generic Injectables Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 10: Generic Injectables Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 11: Generic Injectables Manufacturing Plant: Costs Related to Machinery Unit (in US$)
Table 12: Generic Injectables Manufacturing Plant: Raw Material Requirements (Kg/Day) and Expenditures (US$/Kg)
Table 13: Generic Injectables Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 14: Generic Injectables Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 15: Details of Financial Assistance Offered by Financial Institutions
Table 16: Generic Injectables Manufacturing Plant: Capital Costs (in US$)
Table 17: Generic Injectables Manufacturing Plant: Techno-Economic Parameters (in US$)
Table 18: Generic Injectables Manufacturing Plant: Taxation and Depreciation (in US$)
Table 19: Generic Injectables Manufacturing Plant: Income Projections (in US$)
Table 20: Generic Injectables Manufacturing Plant: Expenditure Projections (in US$)
Table 21: Generic Injectables Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability (in US$)
Table 22: Generic Injectables Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability (in US$)
Table 23: Generic Injectables Manufacturing Plant: Profit and Loss Account (in US$)

Generic Injectables Market Report by Therapeutic Area (Oncology, Anaesthesia, Anti-infectives, Parenteral Nutrition, Cardiovascular), Container (Vials, Ampoules, Premix, Prefilled Syringes), Distribution Channel (Hospitals, Retail Pharmacy), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More